Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank

被引:34
作者
Chen, Justin [1 ]
Zaman, Amanda [1 ]
Ramakrishna, Bharat [1 ]
Olesen, Scott W. [1 ]
机构
[1] OpenBiome, Cambridge, MA 02140 USA
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2021年 / 11卷
关键词
Clostridioides (Clostridium) difficile infection; microbiome; stool banks; stool donor screening; fecal microbiota transplantation; CLOSTRIDIUM-DIFFICILE INFECTION; RECURRENT; FROZEN; EFFICACY; DONORS; RISK;
D O I
10.3389/fcimb.2021.622949
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives Fecal microbiota transplantation (FMT) is a recommended therapy for recurrent Clostridioides difficile infection and is being investigated as a potential therapy for dozens of microbiota-mediated indications. Stool banks centralize FMT donor screening and FMT material preparation with the goal of expanding access to FMT material while simultaneously improving its safety, quality, and convenience. Although there are published consensuses on donor screening guidelines, there are few reports about the implementation of those guidelines in functioning stool banks. Methods To help inform consensus standards with data gathered from real-world settings and, in turn, to improve patient care, here we describe the general methodology used in 2018 by OpenBiome, a large stool bank, and its outputs in that year. Results In 2018, the stool bank received 7,536 stool donations from 210 donors, a daily average of 20.6 donations, and processed 4,271 of those donations into FMT preparations. The median time a screened and enrolled stool donor actively donated stool was 5.8 months. The median time between the manufacture of an FMT preparation and its shipment to a hospital or physician was 8.9 months. Half of the stool bank's partner hospitals and physicians ordered an average of 0.75 or fewer FMT preparations per month. Conclusions Further knowledge sharing should help inform refinements of stool banking guidelines and best practices.
引用
收藏
页数:13
相关论文
共 80 条
[1]  
Agrawal M, 2016, J CLIN GASTROENTEROL, V50, P403, DOI 10.1097/MCG.0000000000000410
[2]   Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation [J].
Allegretti, Jessica R. ;
Elliott, Ryan J. ;
Ladha, Alim ;
Njenga, Mary ;
Warren, Kurt ;
O'Brien, Kelsey ;
Budree, Shrish ;
Osman, Majdi ;
Fischer, Monika ;
Kelly, Colleen R. ;
Kassam, Zain .
GUT MICROBES, 2020, 11 (06) :1806-1808
[3]   The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications [J].
Allegretti, Jessica R. ;
Mullish, Benjamin H. ;
Kelly, Colleen ;
Fischer, Monika .
LANCET, 2019, 394 (10196) :420-431
[4]   Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose [J].
Allegretti, Jessica R. ;
Fischer, Monika ;
Sagi, Sashidhar, V ;
Bohm, Matthew E. ;
Fadda, Hala M. ;
Ranmal, Sejal R. ;
Budree, Shrish ;
Basit, Abdul W. ;
Glettig, Dean L. ;
de la Serna, Eva L. ;
Gentile, Amanda ;
Gerardin, Ylaine ;
Timberlake, Sonia ;
Sadovsky, Rotem ;
Smith, Mark ;
Kassam, Zain .
DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) :1672-1678
[5]  
Allegretti JR., 2016, GASTROENTEROLOGY, V150, pS540, DOI [10.1016/S0016-5085(16)31855-8, DOI 10.1016/S0016-5085(16)31855-8, 10.1016/s0016-5085(16)31855-8]
[6]  
Alm E., 2019, ACG ANN SCI M
[7]  
American Association of Blood Banks, 2019, FAQS BLOOD BLOOD DON
[8]   Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians [J].
Bakken, Johan S. ;
Polgreen, Philip M. ;
Beekmann, Susan E. ;
Riedo, Francis X. ;
Streit, Judy A. .
ANAEROBE, 2013, 24 :20-24
[9]   Treating Clostridium difficile Infection With Fecal Microbiota Transplantation [J].
Bakken, Johan S. ;
Borody, Thomas ;
Brandt, Lawrence J. ;
Brill, Joel V. ;
Demarco, Daniel C. ;
Franzos, Marc Alaric ;
Kelly, Colleen ;
Khoruts, Alexander ;
Louie, Thomas ;
Martinelli, Lawrence P. ;
Moore, Thomas A. ;
Russell, George ;
Surawicz, Christina .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (12) :1044-1049
[10]  
Bibbò S, 2017, MINERVA GASTROENT D, V63, P420, DOI 10.23736/S1121-421X.17.02374-1